Arvest Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,157
Closed -$1.04M 160
2022
Q4
$1.04M Buy
11,157
+131
+1% +$12.6K 0.07% 95
2022
Q3
$1.05M Buy
11,026
+7,931
+256% +$785K 0.07% 96
2022
Q2
$286K Sell
3,095
-39
-1% -$3.81K 0.02% 125
2022
Q1
$317K Sell
3,134
-517
-14% -$54.3K 0.02% 138
2021
Q4
$377K Buy
+3,651
New +$337K 0.02% 127
2014
Q2
$13.7M Buy
181,827
+538
+0.3% +$40.7K 1.27% 27
2014
Q1
$13.2M Sell
181,289
-93,354
-34% -$6.59M 1.27% 30
2013
Q4
$19.7M Sell
274,643
-6,617
-2% -$425K 1.95% 12
2013
Q3
$16M Sell
281,260
-2,007
-0.7% -$120K 1.75% 16
2013
Q2
$16.2M Buy
+283,267
New +$16.4M 1.85% 14

Other funds holding CVS

Arvest Trust's CVS Position: Q1 2023 in Review

Arvest Trust sold out of CVS Health (CVS) in Q1 2023, closing a stake of 11,157 shares — an estimated $1.04M sold.

Arvest Trust first reported a position in CVS in Q2 2013 and held it in 10 quarters. The position peaked at $19.7M in Q4 2013. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Arvest Trust reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Arvest Trust sold 11,157 CVS Health shares in Q1 2023, an estimated $1.04M.
  • Arvest Trust first reported a position in CVS Health in Q2 2013 and held it in 10 quarters.
  • Arvest Trust's CVS Health position peaked at $19.7M in Q4 2013.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Arvest Trust's 13F filing for Q1 2023, filed 11 May 2023.